Nobukazu Tanabe

Sendai, 9830045, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: March 10, 2026

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Journal: Cancers

Published: March 20, 2025

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.

Journal: Cancer medicine

Published: January 24, 2025

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.

Journal: Liver cancer

Published: March 08, 2023

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage.

A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage.

Journal: Scientific reports

Published: February 24, 2023

Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan.

Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan.

Journal: Scientific reports

Published: February 04, 2022

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.

Journal: Liver cancer

Published: December 03, 2021

Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy.

Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy.

Journal: Liver cancer

Published: October 18, 2021

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

Journal: Gut

Published: May 01, 2019

Successful treatment of refractory gastric antral vascular ectasia using transcatheter arterial embolization.

Successful treatment of refractory gastric antral vascular ectasia using transcatheter arterial embolization.

Journal: Clinical journal of gastroenterology

Published: January 22, 2013

Successful treatment of a case of advanced sigmoid colon cancer with occlusion of the common celiacomesenteric trunk

Successful treatment of a case of advanced sigmoid colon cancer with occlusion of the common celiacomesenteric trunk

Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

Published: June 13, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026